#AANAM – Zolgensma May Lead to Faster, Greater Gains Than Spinraza

#AANAM – Zolgensma May Lead to Faster, Greater Gains Than Spinraza

292707

#AANAM – Zolgensma May Lead to Faster, Greater Gains Than Spinraza

Zolgensma may result in faster and greater functional improvements than Spinraza (nusinersen) in infants with spinal muscular atrophy (SMA) treated up to 2 years of age, according to a survey of 22 health providers in the U.S. Given the survey’s limitations, such as its small sample and subjective nature, larger and more objective studies are needed to confirm these findings, the researchers noted. The survey results, “Outcomes of Single-Agent Onasemnogene Abeparvovec or Nusinersen, and of Nusinersen…

You must be logged in to read/download the full post.